KARI THOMAS: Open Payments
NPI 1073606505 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 48 payments from 16 companies in 2025. Trend: 2023 $779 · 2024 $1,003 · 2025 $841
Food & beverage: $825Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $195 |
| PFIZER INC. | 9 | $156 |
| Amgen Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $76 |
| ABBVIE INC. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Philips North America LLC | 1 | $33 |
| LeMaitre Vascular, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
Products named: LEQVIO, ELIQUIS, REPATHA, CAMZYOS, AMVUTTRA, Ambulatory Monitoring & Diagnostics Undivided, HYDRO LEMAITRE VALVULOTOME, JARDIANCE.
Industry payments across ND — which companies pay providers there.
